Literature DB >> 7961219

The postantibiotic effect of antifungal agents against common pathogenic yeasts.

J D Turnidge1, S Gudmundsson, B Vogelman, W A Craig.   

Abstract

A total of ten strains of Candida spp. and Cryptococcus neoformans were examined for the presence of the postantibiotic effect (PAE) after 0.5-2 h exposure to amphotericin B, 5-fluorocytosine, miconazole and ketoconazole. Significant PAEs were observed for amphotericin B and 5-fluorocytosine, but none for the imidazoles. The duration of the PAEs of amphotericin B ranged from 0.5-10.4 h for the Candida spp. and 2.8-10.6 h for the cryptococcos, while 5-fluorocytosine induced PAEs from 0.8-7.4 h and 2.4-5.4 h, respectively. Even though no PAEs were demonstrated for the imidazoles, the growth rate was persistently reduced by continuous exposure to concentrations as low as 1/1000 of the MIC of these agents. These findings may have implications for dosing antifungal agents in systemic yeast infections.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961219     DOI: 10.1093/jac/34.1.83

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  29 in total

1.  Assessment of the effect of amphotericin B on the vitality of Candida albicans.

Authors:  R S Liao; R P Rennie; J A Talbot
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

2.  Miconazole induces fungistasis and increases killing of Candida albicans subjected to photodynamic therapy.

Authors:  Sara B Snell; Thomas H Foster; Constantine G Haidaris
Journal:  Photochem Photobiol       Date:  2011-12-20       Impact factor: 3.421

Review 3.  In vivo pharmacodynamics of antifungal drugs in treatment of candidiasis.

Authors:  David Andes
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

4.  In vivo pharmacodynamics of HMR 3270, a glucan synthase inhibitor, in a murine candidiasis model.

Authors:  D Andes; K Marchillo; J Lowther; A Bryskier; T Stamstad; R Conklin
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

Review 5.  Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy.

Authors:  A H Groll; H Kolve
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-11       Impact factor: 3.267

Review 6.  Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.

Authors:  Rina Mehrotra; Raffaele De Gaudio; Mark Palazzo
Journal:  Intensive Care Med       Date:  2004-11-05       Impact factor: 17.440

7.  In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effect.

Authors:  S M Gunderson; H Hoffman; E J Ernst; M A Pfaller; M E Klepser
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

8.  Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts.

Authors:  Cristina de Castro Spadari; Taissa Vila; Sonia Rozental; Kelly Ishida
Journal:  Antimicrob Agents Chemother       Date:  2018-07-27       Impact factor: 5.191

9.  Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments.

Authors:  Cornelius J Clancy; Hong Huang; Shaoji Cheng; Hartmut Derendorf; M Hong Nguyen
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

10.  Pharmacodynamics and dose-response relationships of liposomal amphotericin B against different azole-resistant Aspergillus fumigatus isolates in a murine model of disseminated aspergillosis.

Authors:  Seyedmojtaba Seyedmousavi; Willem J G Melchers; Johan W Mouton; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2013-02-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.